Chimera Biotec Overview

  • Founded
  • 2000
  • Status
  • Private
  • Employees
  • 11
  • Latest Deal Type
  • Undetermined
  • Financing Rounds
  • 2

Chimera Biotec General Information


Developer and marketer of ligand-binding assays for pharmacokinetic, pharmacodynamics and biomarker applications. The company primarily focuses on manufacturing conjugates of antibodies and DNA with novel reagents and improved properties. It also provides immunoassay system for ultra sensitive analyte detection.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Emil-Figge-Street. 76 A
  • 44227 Dortmund
  • Germany
+49 0231 0000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Chimera Biotec Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Chimera Biotec‘s full profile, request access.

Request a free trial

Chimera Biotec Executive Team (2)

Name Title Board Seat Contact Info
Mark Spengler Chief Executive Officer & Director, Project Management
To view Chimera Biotec’s complete executive team members history, request access »

Chimera Biotec Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial